Pharma & drug development · Reference
What is pharmacokinetics?
Pharmacokinetics (PK) is the study of what the body does to a drug over time. It describes how a drug is absorbed, distributed, metabolised and excreted — the ADME processes — using measures such as half-life and clearance.
The ADME processes
Pharmacokinetics is organised around ADME. Absorption describes how a drug enters the bloodstream from its site of administration; distribution describes how it moves into tissues and fluids; metabolism describes how the body chemically transforms it, often in the liver; and excretion describes how it and its metabolites leave the body, often via the kidneys. Together these processes determine how much drug is present at any moment and for how long. Pharmacokinetics is the “what the body does to the drug” counterpart to pharmacodynamics.
Key parameters: half-life and clearance
Pharmacokinetics turns these processes into measurable parameters. Half-life is the time it takes for the drug concentration to fall by half, which helps describe how long a drug persists. Clearance is the rate at which the body removes the drug, and volume of distribution reflects how extensively a drug spreads into tissues relative to the blood. Bioavailability captures the fraction of an administered dose that reaches the systemic circulation. These are conceptual descriptors of drug behaviour for research and educational purposes — they are not dosing instructions.
Why pharmacokinetics matters
Pharmacokinetics is central to drug development. Researchers characterise a candidate’s PK in preclinical studies and in early-phase trials to understand how it behaves, which informs study design and the questions later trials must answer. A compound that is poorly absorbed or cleared too quickly may need reformulation or may be set aside.
PK also helps explain why different formulations or routes of administration behave differently, and why drugs are studied carefully before use. As a research discipline it provides the quantitative language for how drug exposure arises over time, without offering advice on any individual’s treatment.
Key facts
At a glance
- Definition: What the body does to a drug over time
- ADME: Absorption, distribution, metabolism, excretion
- Half-life: Time for concentration to fall by half
- Clearance: Rate at which the body removes the drug
- Counterpart: Pharmacodynamics (what the drug does to the body)
- Used in: Drug development and study design
Common questions
FAQ
What is pharmacokinetics in simple terms?+
Pharmacokinetics is the study of what happens to a drug inside the body — how it is absorbed, spread around, broken down and removed over time. It is a research and educational concept, not personal dosing guidance.
What does ADME stand for in pharmacokinetics?+
ADME stands for absorption, distribution, metabolism and excretion — the four processes that describe a drug’s journey through the body and together make up pharmacokinetics.
What is drug half-life?+
Half-life is the time it takes for the concentration of a drug in the body to fall to half its value. It is a descriptive pharmacokinetic measure of how long a drug persists, used in research rather than as a dosing rule.
The step most authors miss
Doing CRediT right? Don’t stop at the statement.
A CRediT statement credits you inside one paper. The recognition CRediT was built for happens when those roles are tied to you, persistently. Sign in with your ORCID — free — and claim your CRediT contributions on casrai.org, the home of the standard. They become a verified, portable part of your identity, not a line that disappears into one PDF.
Free: claim your contributions, then export a journal-ready CRediT statement, schema.org structured data, JATS XML, CSV or BibTeX — and preview your public profile. A membership publishes that profile publicly and verifies the journals you serve.
